HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
3,3-Difluoropiperidine hydrochloride → 1-{3-Chloro-6-[2-(3,3-difluoro-piperidin-1-yl)-ethoxy]-5-[3-(4-fluoro-phenyl)-butoxy]-4-methoxy-2-methyl-phenyl}-ethanone
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | 3,3-Difluoropiperidine hydrochloride | HCID 2758349 | — |
| Edukt | 1-{2-(2-Bromo-ethoxy)-5-chloro-3-[3-(4-fluoro-phenyl)-butoxy]-4-methoxy-6-methyl-phenyl}-ethanone | HCID 59583523 | — |
| Produkt | 1-{3-Chloro-6-[2-(3,3-difluoro-piperidin-1-yl)-ethoxy]-5-[3-(4-fluoro-phenyl)-butoxy]-4-methoxy-2-methyl-phenyl}-ethanone | HCID 25254841 | 33% |
Reaktionsschritte
Example 8a (101 mg, 0.21 mmol) was reacted with 3,3-difluoropiperidine hydrochloride (2.5 eq.) as described under General Procedure K to afford the title compound (37 mg, 33%) as a clear oil. 1H NMR (300 MHz, CDCl3) δ 7.20-7.15 (m, 2H), 7.01-6.95 (m, 2H), 4.07 (t, J=5.4 Hz, 2H), 3.97 (td, J=6.9, 1.5 Hz, 2H), 3.83 (s, 3H), 3.05-2.83 (m, 1H), 2.75-2.68 (m, 4H), 2.50-2.46 (m, 5H), 2.18 (s, 3H), 2.13-1.94 (m, 2H), 1.90-1.74 (m, 4H), 1.29 (d, J=6.9 Hz, 3H). MS (ES+) m/z 528 (M+H+).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US08202513B2 |
| Quelldatensatz | uspto-grants-2012_06 |
| ORD ID | ord-0209539499054c3ea2f093ac44d579cb |
| Quellennotiz | uspto-grants-2012_06 |